Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Recent advances in the management of autoimmune myocarditis: insights from animal studies.

Author(s): Kazuko Tajiri, Yasuhiro Yasutomi and Kazutaka Aonuma

Volume 22, Issue 4, 2016

Page: [427 - 439] Pages: 13

DOI: 10.2174/1381612822666151222160702

Price: $65

Abstract

A growing body of evidence has been accumulating to demonstrate that human myocarditis and dilated cardiomyopathy involve a complex interaction with autoimmunity triggered by cardiotropic microbial infections. Animal experiments have provided direct evidence that infections with a particular microbe can incite autoimmune myocarditis, and this autoimmune response can be mimicked by immunization with the cardiac autoantigen, - myosin. Animal models greatly advanced our understanding of the molecular mechanisms of myocarditis, and various novel therapeutic strategies have been reported during the last two decades. In this review we present animal models of autoimmune myocarditis and describe the outlook of possible drug targets by showing the latest findings from animal studies.

Keywords: Autoimmune myocarditis, suppressor of cytokine signaling, immune tolerance, statin, matricellular protein, dilated cardiomyopathy, animal model.


Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy